Exon architecture controls mRNA m<sup>6</sup>A suppression and gene expression.

He, P Cody; Wei, Jiangbo; Dou, Xiaoyang; Harada, Bryan T; Zhang, Zijie; Ge, Ruiqi; Liu, Chang; Zhang, Li-Sheng et al. · Science · 2023

basic_science · Level V

Where this comes from

Abstract

<i>N</i><sup>6</sup>-methyladenosine (m<sup>6</sup>A) is the most abundant messenger RNA (mRNA) modification and plays crucial roles in diverse physiological processes. Using a massively parallel assay for m<sup>6</sup>A (MPm<sup>6</sup>A), we discover that m<sup>6</sup>A specificity is globally regulated by suppressors that prevent m<sup>6</sup>A deposition in unmethylated transcriptome regions. We identify exon junction complexes (EJCs) as m<sup>6</sup>A suppressors that protect exon junction-proximal RNA within coding sequences from methylation and regulate mRNA stability through m<sup>6</sup>A suppression. EJC suppression of m<sup>6</sup>A underlies multiple global characteristics of mRNA m<sup>6</sup>A specificity, with the local range of EJC protection sufficient to suppress m<sup>6</sup>A deposition in average-length internal exons but not in long internal and terminal exons. EJC-suppressed methylation sites colocalize with EJC-suppressed splice sites, which suggests that exon architecture broadly determines local mRNA accessibility to regulatory complexes.

Medical subject headings